POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

An Angel, A Ribbon, An Apple, A Cross

Four More Years!

A Dull Presidency

The Party's Over

Outside Looking In

Clinton & AIDS: A Report Card

Citizen Duane

Great Shape

Behind the Briefs

Butt (It) Itches

Drugs of Ill-Repute

In Defense of Sex

Babes in Boyland

A Treatment Named Desire

Jesse Helms Must Die

Does Dole Have AIDS?

Hit by a MAC Treatment

Energy Booster

Loads of Information



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV



email print

November 1996


Drugs of Ill-Repute

Researchers at Johns Hopkins studied 1,450 people with HIV for five years tracking the incidence of "adverse events" linked to the use of AIDS drugs. The results? Glaxo Wellcome dinosaur AZT caused 203 such events, more than all other therapies combined. The runner-up was Bactrim, with 99. Third place went to ddI, with 21. ddc and dapsone tied for fourth, with 17. Adverse-event rates increased progressively as CD4 counts declined. Women were more likely than men to have problems with dapsone, and whites had a more significant risk of failing Bactrim than nonwhites.


email print

[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Community
Advocacy
Job Listings
Events Calendar
Starting Treatment
My Cool Tools


    dambitious
    Baltimore Co.
    Maryland


    mtfreek1975
    Indianapolis
    Indiana


    Tuffie
    Washington DC
    DC


    damone
    miami
    Florida
Click here to join POZ Personals!
Talk to Us
Poll
Should medical marijuana be legal nationwide?
Yes
No

Survey
What Would You Do to End AIDS?

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.